Cargando…
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification
BACKGROUND: N6-methyladenosine (m(6)A) has emerged as a significant regulator of the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains unclear. Here, we explored the biological function and underlying mechanism of methyltransferase-like 3 (METTL3), the main catalys...
Autores principales: | Xu, Yiming, Lv, Dandan, Yan, Chao, Su, Hua, Zhang, Xue, Shi, Yangfeng, Ying, Kejing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742440/ https://www.ncbi.nlm.nih.gov/pubmed/34996469 http://dx.doi.org/10.1186/s12935-021-02433-6 |
Ejemplares similares
-
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023) -
SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022) -
Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
por: Fan, Zhuoyang, et al.
Publicado: (2021) -
Prognostic role of METTL1 in glioma
por: Li, Lun, et al.
Publicado: (2021) -
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)